|
Cathy,
You are most welcomed. I apologize for the long form answer but at least it gives you a context and some additional background information.
As always, if you have anymore questions regarding my post, don't hesitate to ask. It would have been easier to draw you a picture. Bye-the-bye, I'm an international finance attorney not a researcher. I've been collecting and evaluating HER-2 information for about two years. My mom was diagnosed with HER-2 positive breast cancer in April 2002 and I'm assisting her in the management of her case.
In regard to my mom's case, I discovered early on that even at the best medical facilities in the U.S., it helps to possess a working background with respect to HER-2 and related topics. I view HER-2 positive breast cancer as a sub-specialty within breast cancer oncology. But, as you know, very few oncologist possess a pure HER-2 specialty other than select M.D./Ph.D's in the field (e.g., Drs. Dennis Slamon, Charles Vogel, Melody Cobleigh, Matthew Ellis, and Mark Pegram).
It never hurts to assist your oncologist(s) with whatever studies or information you find. The pace of cellular science and technology in this area is moving at breakneck speed! It is difficult for any doctor or nondoctor to keep pace. The patient needs to be an advocate and work with her team of doctors as a team.
|